Johnson & Johnson (JNJ) is nearing a deal to buy Pharmacyclics Inc. (PCYC), a developer of cancer treatments, the Financial Times reported Wednesday on its website, citing people familiar with the matter.

A deal could be reached in the coming days, although talks could still fall apart, the people told the FT.

Last month Bloomberg News, citing people with knowledge of the matter, reported that J&J and Novartis AG (NVS) had shown interest in buying Pharmacyclics.

Web site: www.ft.com

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Johnson and Johnson Charts.